Kazia Therapeutics (KZIA) Payables (2011 - 2025)
Kazia Therapeutics' (KZIA) quarterly Payables came in at $6.4 million in Q4 2025, down 7.68% YoY from $6.9 million in Q4 2024, and down 4.94% on a QoQ basis from $6.7 million in Q2 2025.
Kazia Therapeutics (KZIA) Payables (2011 - 2025) Analysis & Trends
Kazia Therapeutics (KZIA) has 12 years of Payables data on file, last reported at $6.4 million in Q4 2025.
- Quarterly Payables fell 7.68% year-over-year to $6.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.4 million (down 7.68% YoY) and the FY2025 annual result came in at $6.7 million, down 34.94% from the prior year.
- Payables retreated to $6.4 million in Q4 2025, from $6.7 million in the prior quarter.
- In the past five years, Payables ranged from a high of $10.3 million in Q2 2024 to a low of $1.4 million in Q2 2022.
- A 5-year average of $5.1 million and a median of $4.1 million in 2023 frame the typical range for Payables.
- Annual changes were most pronounced in 2022 — Payables sank 63.83% — and 2023, when it soared 197.98%.
- Tracing KZIA's Payables over 5 years: stood at $3.8 million in 2021, then sank by 35.99% to $2.4 million in 2022, then soared by 69.89% to $4.1 million in 2023, then jumped by 67.8% to $6.9 million in 2024, then fell by 7.68% to $6.4 million in 2025.
- The last three Payables figures came in at $6.4 million (Q4 2025), $6.7 million (Q2 2025), and $6.9 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Kazia Therapeutics | 4.22 Bn | 4.22 Bn | - | 6.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.40 Mn |
| Jun 30, 2025 | 6.73 Mn |
| Dec 31, 2024 | 6.93 Mn |
| Jun 30, 2024 | 10.35 Mn |
| Dec 31, 2023 | 4.13 Mn |
| Jun 30, 2023 | 4.09 Mn |
| Dec 31, 2022 | 2.43 Mn |
| Jun 30, 2022 | 1.37 Mn |
| Jun 30, 2021 | 3.80 Mn |
| Jun 30, 2020 | 2.29 Mn |
| Dec 31, 2019 | 380,641.43 |
| Jun 30, 2019 | 1.24 Mn |
| Jun 30, 2018 | 1.56 Mn |
| Jun 30, 2017 | 1.41 Mn |
| Dec 31, 2014 | 2.32 Mn |
| Oct 3, 2014 | 2,498.81 Bn |
| Jun 30, 2014 | 2.52 Mn |
| Dec 31, 2013 | -22,985.26 Bn |
| Jun 30, 2013 | 1.41 Mn |
| Jun 30, 2011 | 1.11 Mn |